https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
GAS2L1 is thus proposed as a novel biomarker of pancreatic cancer CTCs.Thyroid cancer incidence has increased worldwide; however, investigations of thyroid cancer-related factors as potential prognosis markers remain insufficient. Secreted proteins from the cancer secretome are regulators of several molecular mechanisms and are, thereby, ideal candidates for potential markers. We aimed to identify a specific factor for thyroid cancer by analyzing the secretome from normal thyroid cells, papillary thyroid cancer (PTC) c
Like
Comment
Share
